Ebola Virus Disease News and Research

Latest Ebola Virus Disease News and Research

LSU Health New Orleans researcher discovers fragment of toxic Ebola virus protein

William Gallaher, PhD, Emeritus Professor of Microbiology, Immunology & Parasitology at LSU Health New Orleans School of Medicine, has discovered a fragment of an Ebola virus protein that is toxic to cells and may contribute to infection and illness.

22 Jan 2015

Researchers find link between human population density and spread of Ebola virus in forested regions

Researchers at SUNY Downstate Medical Center have found an apparent link between human population density and vegetation cover in Africa and the spread of the Ebola virus from animal hosts to humans.

22 Jan 2015

NetHope announces new partnership to expand support to combat Ebola outbreak in West Africa

NetHope, a consortium of 42 leading international humanitarian organizations, announced today a partnership with Facebook, the Paul G. Allen Family Foundation, Cisco, EveryLayer and Inveneo to expand their support for effective communications capabilities to combat the Ebola outbreak in West Africa and promote sustainable recovery in the region.

21 Jan 2015

COMPARE project aims to speed up global response to infectious disease outbreaks

A large EU project intends to speed up the detection of and response to disease outbreaks among humans and animals worldwide through the use of new genome technology. The aim is to reduce the impact and cost of disease outbreaks. To that end 28 European partners, including the Technical University of Denmark, have received more than 20 million euro in funding from the EU.

21 Jan 2015

Changes in current Ebola virus epidemic could potentially interfere with experimental treatments

Researchers have tracked the genetic mutations that have occurred in the Ebola virus during the last four decades. Their findings, published in mBio, the online open-access journal of the American Society for Microbiology, identified changes in the current West African outbreak strain that could potentially interfere with experimental, sequence-based therapeutics.

21 Jan 2015

UC RUSAL announces opening of new epidemic and microbiological research centre in Guinea

UC RUSAL, a leading global aluminium producer, announces that construction of the "Centre for epidemic and microbiological research and treatment" in the Kindia administrative region of the Republic of Guinea has completed.

19 Jan 2015

Increase in Lassa fever cases could be due to human-to-human transmission, research reveals

One in five cases of Lassa fever - a disease that kills around 5,000 people a year in West Africa - could be due to human-to-human transmission, with a large proportion of these cases caused by 'super-spreaders', according to research published today in the journal PLOS Neglected Tropical Diseases.

16 Jan 2015

New computer model could predict responses to disease outbreak

Sometimes the response to the outbreak of a disease can make things worse -- such as when people panic and flee, potentially spreading the disease to new areas. The ability to anticipate when such overreactions might occur could help public health officials take steps to limit the dangers.

15 Jan 2015

Ebola epidemic in Liberia could be eliminated by June, finds study

The Ebola epidemic in Liberia could likely be eliminated by June if the current high rate of hospitalization and vigilance can be maintained, according to a new model developed by ecologists at the University of Georgia and Pennsylvania State University.

13 Jan 2015

Obstetric care during Ebola epidemic are deeply challenging

Obstetric interventions during an Ebola epidemic are deeply challenging say two new commentaries published today (14 January) in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG).

13 Jan 2015

H&P Labs announces licensing agreement to develop oral drug therapy against Ebola

H&P Labs Inc. announced an agreement with Harvard University and Brigham and Women's Hospital to license two classes of compounds in order to develop an oral drug therapy against Ebola.

8 Jan 2015

Johnson & Johnson begins Phase 1 trial of preventive Ebola vaccine program

Johnson & Johnson today announced the start of a Phase 1, first-in-human clinical trial of a preventive Ebola vaccine in development at its Janssen Pharmaceutical Companies.

6 Jan 2015

Outbreaks of infectious diseases offer lessons for critical care providers

Outbreaks of infectious diseases, such as Ebola in West Africa, offer insight for how healthcare professionals can respond more effectively to current and future challenges, according to editors of the American Journal of Critical Care.

5 Jan 2015

FDA provides Emergency Use Authorization for Roche's LightMix Ebola Zaire rRT-PCR Test

Roche today announced that the U.S. Food and Drug Administration has provided an Emergency Use Authorization (EUA) for the LightMix Ebola Zaire rRT-PCR Test for use on patients with signs and symptoms of Ebola Zaire virus infection in conjunction with epidemiological risk factors, such as individuals traveling from West Africa.

From Roche Sequencing and Life Science 30 Dec 2014

Protein Sciences earns Frost & Sullivan 2013 Global New Product Innovation Award

Based on its recent analysis of the influenza vaccines market, Frost & Sullivan recognises Protein Sciences with the 2013 Global New Product Innovation Award. Flublok is the world's first recombinant protein vaccine for the prevention of seasonal influenza disease to gain U.S. FDA approval.

29 Dec 2014

Experimental Ebola vaccine safe and immunogenic in African population

Two experimental DNA vaccines to prevent Ebola virus and the closely related Marburg virus [1] are safe, and generated a similar immune response in healthy Ugandan adults as reported in healthy US adults earlier this year.

23 Dec 2014

Infectious disease specialist underscores the importance of flu vaccines

Flu season is in full swing, but it's not too late to get a flu vaccine. In fact, it's never been easier and more convenient.

23 Dec 2014

Canopus BioPharma study confirms efficacy of CB008 drug for Ebola Virus inhibition

Canopus BioPharma Inc. today announces that it has completed crucial research in confirming efficacy of a prescription drug: CB008 for Ebola Virus inhibition.

19 Dec 2014

Experimental drug warrants clinical study for treatment of Ebola infection

A case report, published in The Lancet today, describes the successful treatment of Ebola using a new drug under clinical development for vascular leakage (FX06, a fibrin-derived peptide).

19 Dec 2014

Researchers identify 53 existing drugs that may block Ebola virus from entering human cells

Researchers found 53 existing drugs that may keep the Ebola virus from entering human cells, a key step in the process of infection, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai and the National Institutes of Health, and published today in the Nature Press journal Emerging Microbes and Infections.

17 Dec 2014

Ebola Virus Disease News and Research

Latest Ebola Virus Disease News and Research

LSU Health New Orleans researcher discovers fragment of toxic Ebola virus protein

Researchers find link between human population density and spread of Ebola virus in forested regions

NetHope announces new partnership to expand support to combat Ebola outbreak in West Africa

COMPARE project aims to speed up global response to infectious disease outbreaks

Changes in current Ebola virus epidemic could potentially interfere with experimental treatments

UC RUSAL announces opening of new epidemic and microbiological research centre in Guinea

Increase in Lassa fever cases could be due to human-to-human transmission, research reveals

New computer model could predict responses to disease outbreak

Ebola epidemic in Liberia could be eliminated by June, finds study

Obstetric care during Ebola epidemic are deeply challenging

H&P Labs announces licensing agreement to develop oral drug therapy against Ebola

Johnson & Johnson begins Phase 1 trial of preventive Ebola vaccine program

Outbreaks of infectious diseases offer lessons for critical care providers

FDA provides Emergency Use Authorization for Roche's LightMix Ebola Zaire rRT-PCR Test

Protein Sciences earns Frost & Sullivan 2013 Global New Product Innovation Award

Experimental Ebola vaccine safe and immunogenic in African population

Infectious disease specialist underscores the importance of flu vaccines

Canopus BioPharma study confirms efficacy of CB008 drug for Ebola Virus inhibition

Experimental drug warrants clinical study for treatment of Ebola infection

Researchers identify 53 existing drugs that may block Ebola virus from entering human cells

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Ebola Virus Disease News and Research

Latest Ebola Virus Disease News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in